Albert, F. W. & Kruglyak, L. The position of regulatory variation in advanced traits and illness. Nat. Rev. Genet. 16, 197–212 (2015).
GTEx Consortium. The GTEx Consortium atlas of genetic regulatory results throughout human tissues. Science 369, 1318–1330 (2020).
Chun, S. et al. Restricted statistical proof for shared genetic results of eQTLs and autoimmune-disease-associated loci in three main immune-cell sorts. Nat. Genet. 49, 600–605 (2017).
Umans, B. D., Battle, A. & Gilad, Y. The place are the disease-associated eQTLs? Tendencies Genet. 37, 109–124 (2021).
Nishikura, Okay. Features and regulation of RNA enhancing by ADAR deaminases. Annu. Rev. Biochem. 79, 321–349 (2010).
Rice, G. I. et al. Mutations in ADAR1 trigger Aicardi–Goutieres syndrome related to a sort I interferon signature. Nat. Genet. 44, 1243–1248 (2012).
Mannion, N. M. et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9, 1482–1494 (2014).
Liddicoat, B. J. et al. RNA enhancing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349, 1115–1120 (2015).
Pestal, Okay. et al. Isoforms of RNA-editing enzyme ADAR1 independently management nucleic acid sensor MDA5-driven autoimmunity and multi-organ growth. Immunity 43, 933–944 (2015).
Eisenberg, E. & Levanon, E. Y. A-to-I RNA enhancing—immune protector and transcriptome diversifier. Nat. Rev. Genet. 19, 473–490 (2018).
Samuel, C. E. Adenosine deaminase appearing on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses. J. Biol. Chem. 294, 1710–1720 (2019).
Li, Y. I. et al. RNA splicing is a major hyperlink between genetic variation and illness. Science 352, 600–604 (2016).
Jonkhout, N. et al. The RNA modification panorama in human illness. RNA 23, 1754–1769 (2017).
Walkley, C. R. & Li, J. B. Rewriting the transcriptome: adenosine-to-inosine RNA enhancing by ADARs. Genome Biol. 18, 205 (2017).
Ramaswami, G. & Li, J. B. Identification of human RNA enhancing websites: a historic perspective. Strategies 107, 42–47 (2016).
Ramaswami, G. et al. Correct identification of human Alu and non-Alu RNA enhancing websites. Nat. Strategies 9, 579–581 (2012).
Tan, M. H. et al. Dynamic panorama and regulation of RNA enhancing in mammals. Nature 550, 249–254 (2017).
Porath, H. T., Knisbacher, B. A., Eisenberg, E. & Levanon, E. Y. Large A-to-I RNA enhancing is frequent throughout the metazoa and correlates with dsRNA abundance. Genome Biol. 18, 185 (2017).
Chalk, A. M., Taylor, S., Heraud-Farlow, J. E. & Walkley, C. R. Nearly all of A-to-I RNA enhancing isn’t required for mammalian homeostasis. Genome Biol. 20, 268 (2019).
Rice, G. I. et al. Acquire-of-function mutations in IFIH1 trigger a spectrum of human illness phenotypes related to upregulated sort I interferon signaling. Nat. Genet. 46, 503–509 (2014).
Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J. A. Uncommon variants of IFIH1, a gene implicated in antiviral responses, defend towards sort 1 diabetes. Science 324, 387–389 (2009).
Emdin, C. A. et al. Evaluation of predicted loss-of-function variants in UK Biobank identifies variants protecting for illness. Nat. Commun. 9, 1613 (2018).
Li, Y. et al. Carriers of uncommon missense variants in IFIH1 are protected against psoriasis. J. Make investments. Dermatol. 130, 2768–2772 (2010).
Huang, H. et al. Positive-mapping inflammatory bowel illness loci to single-variant decision. Nature 547, 173–178 (2017).
Jin, Y., Andersen, G. H. L., Santorico, S. A. & Spritz, R. A. A number of purposeful variants of IFIH1, a gene concerned in triggering innate immune responses, defend towards vitiligo. J. Make investments. Dermatol. 137, 522–524 (2017).
Solar, B. B. et al. Genetic associations of protein-coding variants in human illness. Nature 603, 95–102 (2022).
Shallev, L. et al. Decreased A-to-I RNA enhancing as a supply of keratinocytes’ dsRNA in psoriasis. RNA 24, 828–840 (2018).
Vlachogiannis, N. I. et al. Elevated adenosine-to-inosine RNA enhancing in rheumatoid arthritis. J. Autoimmun. 106, 102329 (2020).
Roth, S. H. et al. Elevated RNA enhancing could present a supply for autoantigens in systemic lupus erythematosus. Cell Rep. 23, 50–57 (2018).
Tossberg, J. T., Heinrich, R. M., Farley, V. M., Crooke, P. S. third & Aune, T. M. Adenosine-to-inosine RNA enhancing of Alu double-stranded (ds)RNAs is markedly decreased in a number of sclerosis and unedited Alu dsRNAs are potent activators of proinflammatory transcriptional responses. J. Immunol. 205, 2606–2617 (2020).
Belkadi, A. et al. Identification of genetic variants controlling RNA enhancing and their impact on RNA construction stabilization. Eur. J. Hum. Genet. 28, 1753–1762 (2020).
Ruan, H. et al. GPEdit: the genetic and pharmacogenomic panorama of A-to-I RNA enhancing in cancers. Nucleic Acids Res. 50, D1231–D1237 (2022).
Breen, M. S. et al. International panorama and genetic regulation of RNA enhancing in cortical samples from people with schizophrenia. Nat. Neurosci. 22, 1402–1412 (2019).
Park, E., Jiang, Y., Hao, L., Hui, J. & Xing, Y. Genetic variation and microRNA focusing on of A-to-I RNA enhancing positive tune human tissue transcriptomes. Genome Biol. 22, 77 (2021).
Franzen, O. et al. International evaluation of A-to-I RNA enhancing reveals affiliation with frequent illness variants. PeerJ 6, e4466 (2018).
Park, E. et al. Inhabitants and allelic variation of A-to-I RNA enhancing in human transcriptomes. Genome Biol. 18, 143 (2017).
Wijetunga, N. A. et al. The meta-epigenomic construction of purified human stem cell populations is outlined at cis-regulatory sequences. Nat. Commun. 5, 5195 (2014).
Baeza-Centurion, P., Minana, B., Schmiedel, J. M., Valcarcel, J. & Lehner, B. Combinatorial genetics reveals a scaling legislation for the consequences of mutations on splicing. Cell 176, 549–563.e23 (2019).
Ongen, H., Buil, A., Brown, A. A., Dermitzakis, E. T. & Delaneau, O. Quick and environment friendly QTL mapper for hundreds of molecular phenotypes. Bioinformatics 32, 1479–1485 (2016).
Urbut, S. M., Wang, G., Carbonetto, P. & Stephens, M. Versatile statistical strategies for estimating and testing results in genomic research with a number of situations. Nat. Genet. 51, 187–195 (2019).
Matthews, M. M. et al. Buildings of human ADAR2 sure to dsRNA reveal base-flipping mechanism and foundation for web site selectivity. Nat. Struct. Mol. Biol. 23, 426–433 (2016).
Hormozdiari, F. et al. Leveraging molecular quantitative trait loci to grasp the genetic structure of illnesses and sophisticated traits. Nat. Genet. 50, 1041–1047 (2018).
Finucane, H. Okay. et al. Partitioning heritability by purposeful annotation utilizing genome-wide affiliation abstract statistics. Nat. Genet. 47, 1228–1235 (2015).
Navab, M., Anantharamaiah, G. M., Reddy, S. T., Van Lenten, B. J. & Fogelman, A. M. HDL as a biomarker, potential therapeutic goal, and remedy. Diabetes 58, 2711–2717 (2009).
Zeisbrich, M. et al. Hypermetabolic macrophages in rheumatoid arthritis and coronary artery illness attributable to glycogen synthase kinase 3b inactivation. Ann. Rheum. Dis. 77, 1053–1062 (2018).
Misra, M. Okay., Damotte, V. & Hollenbach, J. A. The immunogenetics of neurological illness. Immunology 153, 399–414 (2018).
Suciu, C. F. et al. Oxidized low density lipoproteins: the bridge between atherosclerosis and autoimmunity. Potential implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic problems. Autoimmun. Rev. 17, 366–375 (2018).
Yao, D. W., O’Connor, L. J., Worth, A. L. & Gusev, A. Quantifying genetic results on illness mediated by assayed gene expression ranges. Nat. Genet. 52, 626–633 (2020).
Sayaman, R. W. et al. Germline genetic contribution to the immune panorama of most cancers. Immunity 54, 367–386.e8 (2021).
Bazak, L. et al. A-to-I RNA enhancing happens at over 100 million genomic websites, positioned in a majority of human genes. Genome Res. 24, 365–376 (2014).
Faghihi, M. A. & Wahlestedt, C. Regulatory roles of pure antisense transcripts. Nat. Rev. Mol. Cell Biol. 10, 637–643 (2009).
Dias Junior, A. G., Sampaio, N. G. & Rehwinkel, J. A balancing act: MDA5 in antiviral immunity and autoinflammation. Tendencies Microbiol. 27, 75–85 (2019).
Wu, B. et al. Structural foundation for dsRNA recognition, filament formation, and antiviral sign activation by MDA5. Cell 152, 276–289 (2013).
Li, P., Zhou, X., Xu, Okay. & Zhang, Q. C. RASP: an atlas of transcriptome-wide RNA secondary construction probing knowledge. Nucleic Acids Res. 49, D183–D191 (2021).
Zhao, W. et al. POSTAR3: an up to date platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Res. 50, D287–D294 (2022).
Reshef, Y. A. et al. Detecting genome-wide directional results of transcription issue binding on polygenic illness danger. Nat. Genet. 50, 1483–1493 (2018).
Patterson, J. B. & Samuel, C. E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: proof for 2 types of the deaminase. Mol. Cell. Biol. 15, 5376–5388 (1995).
Heraud-Farlow, J. E. & Walkley, C. R. The position of RNA enhancing by ADAR1 in prevention of innate immune sensing of self-RNA. J. Mol. Med. 94, 1095–1102 (2016).
Guo, Y. et al. CD40L-dependent pathway is lively at numerous levels of rheumatoid arthritis illness development. J. Immunol. 198, 4490–4501 (2017).
Elkjaer, M. L. et al. Molecular signature of various lesion sorts within the mind white matter of sufferers with progressive a number of sclerosis. Acta Neuropathol. Commun. 7, 205 (2019).
Tokuyama, M. et al. ERVmap evaluation reveals genome-wide transcription of human endogenous retroviruses. Proc. Natl Acad. Sci. USA 115, 12565–12572 (2018).
Numata, Okay. et al. Comparative evaluation of cis-encoded antisense RNAs in eukaryotes. Gene 392, 134–141 (2007).
Ramaswami, G. & Li, J. B. RADAR: a rigorously annotated database of A-to-I RNA enhancing. Nucleic Acids Res. 42, D109–D113 (2014).
Zhang, R. et al. Quantifying RNA allelic ratios by microfluidic multiplex PCR and sequencing. Nat. Strategies 11, 51–54 (2014).
Ramaswami, G. et al. Genetic mapping uncovers cis-regulatory panorama of RNA enhancing. Nat. Commun. 6, 8194 (2015).
Tran, S. S. et al. Widespread RNA enhancing dysregulation in brains from autistic people. Nat. Neurosci. 22, 25–36 (2019).
Storey, J. D. & Tibshirani, R. Statistical significance for genomewide research. Proc. Natl Acad. Sci. USA 100, 9440–9445 (2003).
Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766–D773 (2019).
Bahn, J. H. et al. Genomic evaluation of ADAR1 binding and its involvement in a number of RNA processing pathways. Nat. Commun. 6, 6355 (2015).
Dobin, A. et al. STAR: ultrafast common RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Altschul, S. F., Gish, W., Miller, W., Myers, E. W. & Lipman, D. J. Primary native alignment search device. J. Mol. Biol. 215, 403–410 (1990).
Konkel, M. Okay. et al. Sequence evaluation and characterization of lively human Alu subfamilies based mostly on the 1000 Genomes Pilot Challenge. Genome Biol. Evol. 7, 2608–2622 (2015).
Eggington, J. M., Greene, T. & Bass, B. L. Predicting websites of ADAR enhancing in double-stranded RNA. Nat. Commun. 2, 319 (2011).
Wagih, O. ggseqlogo: A flexible R bundle for drawing sequence logos. Bioinformatics 33, 3645–3647 (2017).
Tian, S. & Das, R. RNA construction by means of multidimensional chemical mapping. Q. Rev. Biophys. 49, e7 (2016).
Danaee, P. et al. bpRNA: large-scale automated annotation and evaluation of RNA secondary construction. Nucleic Acids Res. 46, 5381–5394 (2018).
Purcell, S. et al. PLINK: a device set for whole-genome affiliation and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Pers, T. H., Timshel, P. & Hirschhorn, J. N. SNPsnap: a web-based device for identification and annotation of matched SNPs. Bioinformatics 31, 418–420 (2015).
Gazal, S. et al. Linkage disequilibrium-dependent structure of human advanced traits exhibits motion of destructive choice. Nat. Genet. 49, 1421–1427 (2017).
Rice, G. I. et al. Evaluation of sort I interferon signaling in pediatric inflammatory illness. J. Clin. Immunol. 37, 123–132 (2017).
Giambartolomei, C. et al. Bayesian take a look at for colocalisation between pairs of genetic affiliation research utilizing abstract statistics. PLoS Genet. 10, e1004383 (2014).
Balbin, O. A. et al. The panorama of antisense gene expression in human cancers. Genome Res. 25, 1068–1079 (2015).
Lorenz, R. et al. ViennaRNA bundle 2.0. Algorithms Mol. Biol. 6, 26 (2011).
Zhang, F., Lu, Y., Yan, S., Xing, Q. & Tian, W. SPRINT: an SNP-free toolkit for figuring out RNA enhancing websites. Bioinformatics 33, 3538–3548 (2017).